PureTech Health Statistics

Total Valuation

PureTech Health has a market cap or net worth of GBP 308.40 million. The enterprise value is 132.77 million.

Market Cap	308.40M
Enterprise Value	132.77M

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

PureTech Health has 241.32 million shares outstanding. The number of shares has decreased by -7.34% in one year.

Current Share Class	241.32M
Shares Outstanding	241.32M
Shares Change (YoY)	-7.34%
Shares Change (QoQ)	-10.11%
Owned by Insiders (%)	6.17%
Owned by Institutions (%)	70.60%
Float	162.90M

Valuation Ratios

The trailing PE ratio is 7.62.

PE Ratio	7.62
Forward PE	n/a
PS Ratio	79.97
PB Ratio	0.95
P/TBV Ratio	0.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	3.11
EV / Sales	34.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.24

Financial Position

The company has a current ratio of 9.33, with a Debt / Equity ratio of 0.41.

Current Ratio	9.33
Quick Ratio	9.19
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	-1.23
Interest Coverage	-13.54

Financial Efficiency

Return on equity (ROE) is 6.41% and return on invested capital (ROIC) is -14.55%.

Return on Equity (ROE)	6.41%
Return on Assets (ROA)	-13.10%
Return on Invested Capital (ROIC)	-14.55%
Return on Capital Employed (ROCE)	-24.21%
Revenue Per Employee	68,865
Profits Per Employee	763,253
Employee Count	56
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-3.20M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.29% in the last 52 weeks. The beta is 0.89, so PureTech Health's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	-28.29%
50-Day Moving Average	131.40
200-Day Moving Average	143.20
Relative Strength Index (RSI)	49.21
Average Volume (20 Days)	242,616

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PureTech Health had revenue of GBP 3.86 million and earned 42.74 million in profits. Earnings per share was 0.17.

Revenue	3.86M
Gross Profit	-51.44M
Operating Income	-108.53M
Pretax Income	18.99M
Net Income	42.74M
EBITDA	-107.08M
EBIT	-108.53M
Earnings Per Share (EPS)	0.17

Full Income Statement

Balance Sheet

The company has 302.48 million in cash and 132.26 million in debt, giving a net cash position of 170.23 million or 0.71 per share.

Cash & Cash Equivalents	302.48M
Total Debt	132.26M
Net Cash	170.23M
Net Cash Per Share	0.71
Equity (Book Value)	325.84M
Book Value Per Share	1.38
Working Capital	275.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -107.33 million and capital expenditures -8,786, giving a free cash flow of -107.34 million.

Operating Cash Flow	-107.33M
Capital Expenditures	-8,786
Free Cash Flow	-107.34M
FCF Per Share	-0.44

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,814.19%
Pretax Margin	492.42%
Profit Margin	1,108.33%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PureTech Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	7.34%
Shareholder Yield	n/a
Earnings Yield	13.86%
FCF Yield	-34.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PureTech Health has an Altman Z-Score of 1.88 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.88
Piotroski F-Score	4